Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
84 participants
INTERVENTIONAL
2020-07-01
2024-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Usage of High-resolution Magnetic Resonance Imaging in Patients With Disorders of Consciousness for Early Diagnosis
NCT03475511
Basic Experimental Study of Hippocampal Memory Functions
NCT05945628
Real-time fMRI Neurofeedback Training on the Anterior Insula Based on Interoceptive Processing
NCT05260749
Neurofeedback Removal of Emotional Information From Mind
NCT06460207
fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease
NCT00478491
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will use a randomized, single-blind, parallel group design. Patients with MCI and healthy participants will be assigned to receive feedback from either the hippocampus (experimental group, N=42) or from another brain area (alternate ROI feedback group, N=42). All participants will be instructed to downregulate activity.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
healthy elderly participants receiving feedback from the hippocampus
This group will consist of healthy elderly volunteers, who will receive feedback from their hippocampal activity.
real-time fMRI based neurofeedback from the hippocampus
During real-time fMRI neurofeedback, participants are trained to 'control' hippocampal activity. The training is accomplished by continuously measuring brain activity, analysing it in real-time, and then providing feedback about the current (and the targeted) brain activity to the participant.
healthy elderly participants receiving feedback from another area
This group will consist of healthy elderly volunteers, who will receive feedback from another brain area.
real-time fMRI based neurofeedback from another brain area
During real-time fMRI neurofeedback, participants are trained to 'control' hippocampal activity. The training is accomplished by continuously measuring brain activity, analysing it in real-time, and then providing feedback about the current (and the targeted) brain activity to the participant.
patients with MCI receiving feedback from the hippocampus
This group will consist of patients with mild cognitive impairment, who will receive feedback from their hippocampal activity.
real-time fMRI based neurofeedback from the hippocampus
During real-time fMRI neurofeedback, participants are trained to 'control' hippocampal activity. The training is accomplished by continuously measuring brain activity, analysing it in real-time, and then providing feedback about the current (and the targeted) brain activity to the participant.
patients with MCI receiving feedback from another brain area
This group will consist of patients with mild cognitive impairment, who will receive feedback from another brain area.
real-time fMRI based neurofeedback from another brain area
During real-time fMRI neurofeedback, participants are trained to 'control' hippocampal activity. The training is accomplished by continuously measuring brain activity, analysing it in real-time, and then providing feedback about the current (and the targeted) brain activity to the participant.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
real-time fMRI based neurofeedback from the hippocampus
During real-time fMRI neurofeedback, participants are trained to 'control' hippocampal activity. The training is accomplished by continuously measuring brain activity, analysing it in real-time, and then providing feedback about the current (and the targeted) brain activity to the participant.
real-time fMRI based neurofeedback from another brain area
During real-time fMRI neurofeedback, participants are trained to 'control' hippocampal activity. The training is accomplished by continuously measuring brain activity, analysing it in real-time, and then providing feedback about the current (and the targeted) brain activity to the participant.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fluent in German
* Normal/corrected-to-normal vision
* Written informed consent
Exclusion Criteria
* Current/lifetime severe psychiatric or neurological disorder
* History of seizures
* Psychotropic medication
* Currently/lifetime drug or alcohol abuse
* Brain damage
* Magnetisable implants
60 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
University of Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jessica Peter, PD Dr.
Role: PRINCIPAL_INVESTIGATOR
University of Bern
Stefan Klöppel, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
University of Bern
Frank Scharnowski, Prof. Dr.
Role: STUDY_CHAIR
University of Vienna
Roland Wiest, Prof. Dr.
Role: STUDY_CHAIR
University of Bern
Katharina Klink
Role: STUDY_CHAIR
University of Bern
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SITEM (Swiss Institute for Translational and Entrepreneurial Medicine)
Bern, , Switzerland
University of Zurich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Klink K, Jaun U, Federspiel A, Wunderlin M, Teunissen CE, Kiefer C, Wiest R, Scharnowski F, Sladky R, Haugg A, Hellrung L, Peter J. Targeting hippocampal hyperactivity with real-time fMRI neurofeedback: protocol of a single-blind randomized controlled trial in mild cognitive impairment. BMC Psychiatry. 2021 Feb 9;21(1):87. doi: 10.1186/s12888-021-03091-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1163
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.